Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.

doi:10.1111/cas.14552

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.

Cancer science - 1 Sept 2020

Yasuda Takahiko, Sanada Masashi, Nishijima Dai, Kanamori Takashi, Iijima Yuka, Hattori Hiroyoshi, Saito Akiko, Miyoshi Hiroaki, Ishikawa Yuichi, Asou Norio, Usuki Kensuke, Hirabayashi Shinsuke, Kato Motohiro, Ri Masaki, Handa Hiroshi, Ishida Tadao, Shibayama Hirohiko, Abe Masahiro, Iriyama Chisako, Karube Kennosuke, Nishikori Momoko, Ohshima Koichi, Kataoka Keisuke, Yoshida Kenichi, Shiraishi Yuichi, Goto Hiroaki, Adachi Souichi, Kobayashi Ryoji, Kiyoi Hitoshi, Miyazaki Yasushi, Ogawa Seishi, Kurahashi Hiroki, Yokoyama Hisayuki, Manabe Atsushi, Iida Shinsuke, Tomita Akihiro, Horibe Keizo

Abstract excerpt

Although next-generation sequencing-based panel testing is well practiced in the field of cancer medicine for the identification of target molecules in solid tumors, the clinical utility and clinical issues surrounding panel testing in hematological malignancies have yet to be fully evaluated. We conducted a multicenter prospective clinical sequencing study to verify the feasibility of a panel test for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Hematologic Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Infant, Newborn

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 32619037
DOI: 10.1111/cas.14552
PMCID: PMC7469806

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.PMID 32619037Read ↗

Targeted therapy according to next generation sequencing-based panel sequencingSemantic proximity Read ↗

[NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].Semantic proximity Read ↗

Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignanciesSemantic proximity Read ↗

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Semantic proximity Read ↗

Panel Sequencing for Targeted Therapy Selection in Solid Tumors.Semantic proximity Read ↗

Clinical Benefit and Agenda for Clinical Sequencing Using Cancer Panel Testing: A Retrospective Clinical StudySemantic proximity Read ↗

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor boardSemantic proximity Read ↗

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline AlterationsSemantic proximity Read ↗

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsSemantic proximity Read ↗

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia DiagnosticsSemantic proximity Read ↗

The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceSemantic proximity Read ↗

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.